OBJECTIVE: To determine the effect of ascorbic acid and alpha-tocopherol on oxidative stress and bone mineral density (BMD) in elderly people. DESIGN: A double-blind, controlled clinical assay was carried out in a sample of 90 elderly subjects divided into three age-paired random groups with 30 subjects in each group. Group Tx0 received placebo, group Tx1 received 500 mg of ascorbic acid and 400 IU of alpha-tocopherol, whereas group Tx2 received 1,000 mg of ascorbic acid and 400 IU of alpha-tocopherol, for a 12-month period. MEASUREMENTS: We measured thiobarbituric acid reactive substances (TBARS), total antioxidant status (TAS), superoxide dismutase (SOD), and glutation peroxidase (GPx); BMD was obtained on DXA of hip and spine before and after the 12-month treatment period with supplementation of vitamins C and E. RESULTS: We found a positive correlation between hip-BMD and SOD (r = 0.298, p < 0.05) and GPx (r = 0.214, p < 0.05). Also, a significantly lower decrease of LPO (p < 0.05) was observed as linked with hip bone loss in the Tx2 group than in the Tx0 group. CONCLUSIONS: Our findings suggest that that administration of 1,000 mg of ascorbic acid together with 400 IU of alpha-tocopherol could be useful in preventing or aiding in the treatment of age-related osteoporosis.
RCT Entities:
OBJECTIVE: To determine the effect of ascorbic acid and alpha-tocopherol on oxidative stress and bone mineral density (BMD) in elderly people. DESIGN: A double-blind, controlled clinical assay was carried out in a sample of 90 elderly subjects divided into three age-paired random groups with 30 subjects in each group. Group Tx0 received placebo, group Tx1 received 500 mg of ascorbic acid and 400 IU of alpha-tocopherol, whereas group Tx2 received 1,000 mg of ascorbic acid and 400 IU of alpha-tocopherol, for a 12-month period. MEASUREMENTS: We measured thiobarbituric acid reactive substances (TBARS), total antioxidant status (TAS), superoxide dismutase (SOD), and glutation peroxidase (GPx); BMD was obtained on DXA of hip and spine before and after the 12-month treatment period with supplementation of vitamins C and E. RESULTS: We found a positive correlation between hip-BMD and SOD (r = 0.298, p < 0.05) and GPx (r = 0.214, p < 0.05). Also, a significantly lower decrease of LPO (p < 0.05) was observed as linked with hip bone loss in the Tx2 group than in the Tx0 group. CONCLUSIONS: Our findings suggest that that administration of 1,000 mg of ascorbic acid together with 400 IU of alpha-tocopherol could be useful in preventing or aiding in the treatment of age-related osteoporosis.
Authors: S Parra-Cabrera; M Hernandez-Avila; J Tamayo-y-Orozco; L López-Carrillo; F Meneses-González Journal: Calcif Tissue Int Date: 1996-08 Impact factor: 4.333
Authors: P Faure; P Corticelli; M J Richard; J Arnaud; C Coudray; S Halimi; A Favier; A M Roussel Journal: Clin Chem Date: 1993-05 Impact factor: 8.327
Authors: Shivani Sahni; Kelsey M Mangano; Robert R McLean; Marian T Hannan; Douglas P Kiel Journal: Curr Osteoporos Rep Date: 2015-08 Impact factor: 5.096
Authors: G Iolascon; R Gimigliano; M Bianco; A De Sire; A Moretti; A Giusti; N Malavolta; S Migliaccio; A Migliore; N Napoli; P Piscitelli; G Resmini; U Tarantino; F Gimigliano Journal: J Nutr Health Aging Date: 2017 Impact factor: 4.075
Authors: Urszula T Iwaniec; Russell T Turner; Brenda J Smith; Barbara J Stoecker; Allison Rust; Bo Zhang; Vihas T Vasu; Kishorchandra Gohil; Carroll E Cross; Maret G Traber Journal: Free Radic Biol Med Date: 2013-09-16 Impact factor: 7.376
Authors: Mackenzie L Hagan; Anoosh Bahraini; Jessica L Pierce; Sarah M Bass; Kanglun Yu; Ranya Elsayed; Mohammed Elsalanty; Maribeth H Johnson; Anna McNeil; Paul L McNeil; Meghan E McGee-Lawrence Journal: Calcif Tissue Int Date: 2018-10-24 Impact factor: 4.333